Benzinga's M&A Chatter for Tuesday December 2, 2014

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday December 2, 2014: Apollo Global Management Most Likely Buyer for PetSmart The Rumor:
Apollo Global Management NYSE: APO 0% is said to be the most likely winner for PetSmart, Inc. PETM, according to a source, as reported by the NY Post. The Leon Black-led firm is expected to offer between $78 and $82 per share by the Thursday bid deadline. Shareholder Jana Partners has been pressing for a sale of the pet supply chain. Both Apollo and PetSmart declined comment. PetSmart closed Tuesday at $79.08, a gain of $0.47. Roche to Acquire Ariosa Diagnostics The Deal:
Roche Holding AG RHHBY announced Tuesday, the acquisition of privately-held molecular diagnostics testing service, Ariosa Diagnostics. Terms were not disclosed. The transaction is expected to close in December, 2014. Roche shares closed Tuesday at $37.65, a loss of $0.27. Otsuka to Acquire Avanir for $17.00/Share in Cash The Deal:
Avanir Pharmaceuticals, Inc. AVNR announced Tuesday, that it has agreed to be acquired by Otsuka Holdings Co., Ltd. OTSKY for $17.00 per share in cash, in a transaction which values Avanir at approximately $3.5 billion. Otsuka will launch a tender offer within ten business days to purchase all outstanding shares of Avanir. The transaction is expected to close in Q1 of 2015. Avanir shares rose almost 13% Tuesday, to close at $16.92. Hearing Unconfirmed Market Chatter of Potential Shell Bid for BP The Rumor:
Shares of BP p.l.c. BP surged higher Tuesday, on unconfirmed market chatter that Royal Dutch Shell plc (NYSE: RDS-A) could offer as much as $46.00 per share for the UK-based energy company. Spokespersons for BP and Shell declined comment on the rumor. BP shares rose more than 2% Tuesday, to close at $40.72.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!